Coloplast A/S (CLPBY)
OTCMKTS
· Delayed Price · Currency is USD
9.35
-0.03 (-0.32%)
Jul 15, 2025, 3:59 PM EDT
Coloplast Revenue
Coloplast had revenue of 6.93B DKK in the quarter ending March 31, 2025, with 5.22% growth. This brings the company's revenue in the last twelve months to 27.79B, up 8.89% year-over-year. In the fiscal year ending September 30, 2024, Coloplast had annual revenue of 27.03B with 10.33% growth.
Revenue (ttm)
27.79B DKK
Revenue Growth
+8.89%
P/S Ratio
5.26
Revenue / Employee
1.67M DKK
Employees
16,639
Market Cap
21.17B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
| Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
| Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
| Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
| Sep 30, 2020 | 18.54B | 605.00M | 3.37% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Coloplast News
- 4 weeks ago - Coloplast: Finally Getting Buyable - Seeking Alpha
- 6 weeks ago - Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025 - GlobeNewsWire
- 2 months ago - Coloplast A/S 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Coloplast A/S (CLPBF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons - GlobeNewsWire
- 2 months ago - Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25 - GlobeNewsWire
- 2 months ago - Coloplast A/S GAAP EPS of DKK4.05, revenue of DKK6.93B - Seeking Alpha
- 2 months ago - Coloplast Seeks to Restore Investor Trust With Firing of CEO - Financial Post